Structure Common Stock vs Net Debt Analysis

GPCR Stock

34.01 0.60 1.80%

Structure Therapeutics financial indicator trend analysis is much more than just breaking down Structure Therapeutics prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Structure Therapeutics is a good investment. Please check the relationship between Structure Therapeutics Common Stock and its Net Debt accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

Common Stock vs Net Debt

Common Stock vs Net Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Structure Therapeutics Common Stock account and Net Debt. At this time, the significance of the direction appears to have pay attention.

The correlation between Structure Therapeutics' Common Stock and Net Debt is -0.89. Overlapping area represents the amount of variation of Common Stock that can explain the historical movement of Net Debt in the same time period over historical financial statements of Structure Therapeutics American, assuming nothing else is changed. The correlation between historical values of Structure Therapeutics' Common Stock and Net Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Common Stock of Structure Therapeutics American are associated (or correlated) with its Net Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Net Debt has no effect on the direction of Common Stock i.e., Structure Therapeutics' Common Stock and Net Debt go up and down completely randomly.

Correlation Coefficient

-0.89

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Common Stock

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Most indicators from Structure Therapeutics' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Structure Therapeutics current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Structure Therapeutics American. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators.

At this time, Structure Therapeutics' Tax Provision is relatively stable compared to the past year. As of 11/26/2024, Selling General Administrative is likely to grow to about 34.3 M, while Enterprise Value Over EBITDA is likely to drop (14.07).

	2021	2022	2023	2024 (projected)
Interest Expense	122.2K	1.5M	13.4M	14.1M
Depreciation And Amortization	266.4K	277K	316K	241.8K

Interest Expense Depreciation And Amortization

Structure Therapeutics fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Net Tangible Assets	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Cash And Short Term Investments	Common Stock Shares Outstanding	Short Term Investments	Non Current Liabilities Total	Capital Lease Obligations	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Property Plant And Equipment Gross	Total Current Assets	Capital Stock
Total Assets		0.99	0.98	0.97	0.95	-0.8	1.0	-0.93	-0.96	0.69	0.94	0.97	0.06	0.03	1.0	0.72	1.0	0.07	0.99	0.88	0.99	0.22	0.95	1.0	1.0	1.0
Short Long Term Debt Total	0.99		0.96	0.94	0.98	-0.74	1.0	-0.88	-0.93	0.61	0.9	0.93	-0.05	-0.08	0.99	0.73	0.99	-0.04	1.0	0.87	1.0	0.11	0.98	1.0	0.99	1.0
Other Current Liab	0.98	0.96		1.0	0.88	-0.85	0.98	-0.97	-0.99	0.75	0.98	0.99	0.22	0.2	0.98	0.69	0.98	0.23	0.96	0.87	0.96	0.38	0.88	0.97	0.98	0.96
Total Current Liabilities	0.97	0.94	1.0		0.85	-0.9	0.97	-0.99	-1.0	0.81	0.99	1.0	0.28	0.26	0.97	0.68	0.97	0.29	0.94	0.88	0.95	0.43	0.85	0.96	0.97	0.95
Total Stockholder Equity	0.95	0.98	0.88	0.85		-0.59	0.96	-0.76	-0.83	0.45	0.79	0.84	-0.26	-0.28	0.95	0.72	0.95	-0.25	0.98	0.81	0.97	-0.1	1.0	0.96	0.95	0.97
Net Tangible Assets	-0.8	-0.74	-0.85	-0.9	-0.59		-0.78	0.93	0.91	-0.98	-0.93	-0.9	-0.57	-0.56	-0.8	-0.53	-0.79	-0.58	-0.74	-0.8	-0.76	-0.69	-0.59	-0.78	-0.8	-0.75
Property Plant And Equipment Net	1.0	1.0	0.98	0.97	0.96	-0.78		-0.91	-0.95	0.66	0.93	0.96	0.02	0.0	1.0	0.72	1.0	0.03	1.0	0.88	1.0	0.19	0.96	1.0	1.0	1.0
Net Debt	-0.93	-0.88	-0.97	-0.99	-0.76	0.93	-0.91		0.99	-0.88	-1.0	-0.99	-0.42	-0.4	-0.93	-0.6	-0.92	-0.43	-0.88	-0.87	-0.89	-0.57	-0.76	-0.91	-0.93	-0.89
Retained Earnings	-0.96	-0.93	-0.99	-1.0	-0.83	0.91	-0.95	0.99		-0.84	-1.0	-1.0	-0.32	-0.3	-0.96	-0.63	-0.96	-0.33	-0.93	-0.89	-0.93	-0.47	-0.83	-0.95	-0.96	-0.93
Accounts Payable	0.69	0.61	0.75	0.81	0.45	-0.98	0.66	-0.88	-0.84		0.86	0.83	0.68	0.68	0.68	0.38	0.68	0.69	0.61	0.75	0.64	0.78	0.45	0.66	0.68	0.62
Cash	0.94	0.9	0.98	0.99	0.79	-0.93	0.93	-1.0	-1.0	0.86		1.0	0.39	0.36	0.94	0.64	0.94	0.4	0.9	0.86	0.91	0.53	0.79	0.93	0.94	0.91
Non Current Assets Total	0.97	0.93	0.99	1.0	0.84	-0.9	0.96	-0.99	-1.0	0.83	1.0		0.31	0.28	0.97	0.67	0.97	0.32	0.93	0.87	0.94	0.46	0.84	0.96	0.97	0.94
Non Currrent Assets Other	0.06	-0.05	0.22	0.28	-0.26	-0.57	0.02	-0.42	-0.32	0.68	0.39	0.31		1.0	0.05	-0.06	0.05	1.0	-0.05	0.14	-0.03	0.99	-0.26	0.02	0.05	-0.04
Other Assets	0.03	-0.08	0.2	0.26	-0.28	-0.56	0.0	-0.4	-0.3	0.68	0.36	0.28	1.0		0.03	-0.08	0.03	1.0	-0.08	0.12	-0.05	0.98	-0.28	-0.01	0.03	-0.06
Cash And Short Term Investments	1.0	0.99	0.98	0.97	0.95	-0.8	1.0	-0.93	-0.96	0.68	0.94	0.97	0.05	0.03		0.72	1.0	0.06	0.99	0.88	0.99	0.21	0.95	1.0	1.0	1.0
Common Stock Shares Outstanding	0.72	0.73	0.69	0.68	0.72	-0.53	0.72	-0.6	-0.63	0.38	0.64	0.67	-0.06	-0.08	0.72		0.72	-0.06	0.73	0.33	0.72	0.05	0.72	0.72	0.72	0.73
Short Term Investments	1.0	0.99	0.98	0.97	0.95	-0.79	1.0	-0.92	-0.96	0.68	0.94	0.97	0.05	0.03	1.0	0.72		0.06	0.99	0.88	0.99	0.21	0.95	1.0	1.0	1.0
Non Current Liabilities Total	0.07	-0.04	0.23	0.29	-0.25	-0.58	0.03	-0.43	-0.33	0.69	0.4	0.32	1.0	1.0	0.06	-0.06	0.06		-0.04	0.15	-0.02	0.99	-0.25	0.03	0.06	-0.03
Capital Lease Obligations	0.99	1.0	0.96	0.94	0.98	-0.74	1.0	-0.88	-0.93	0.61	0.9	0.93	-0.05	-0.08	0.99	0.73	0.99	-0.04		0.87	1.0	0.11	0.98	1.0	0.99	1.0
Other Current Assets	0.88	0.87	0.87	0.88	0.81	-0.8	0.88	-0.87	-0.89	0.75	0.86	0.87	0.14	0.12	0.88	0.33	0.88	0.15	0.87		0.88	0.28	0.81	0.88	0.88	0.87
Other Stockholder Equity	0.99	1.0	0.96	0.95	0.97	-0.76	1.0	-0.89	-0.93	0.64	0.91	0.94	-0.03	-0.05	0.99	0.72	0.99	-0.02	1.0	0.88		0.13	0.97	1.0	0.99	1.0
Total Liab	0.22	0.11	0.38	0.43	-0.1	-0.69	0.19	-0.57	-0.47	0.78	0.53	0.46	0.99	0.98	0.21	0.05	0.21	0.99	0.11	0.28	0.13		-0.1	0.18	0.22	0.13
Net Invested Capital	0.95	0.98	0.88	0.85	1.0	-0.59	0.96	-0.76	-0.83	0.45	0.79	0.84	-0.26	-0.28	0.95	0.72	0.95	-0.25	0.98	0.81	0.97	-0.1		0.96	0.95	0.97
Property Plant And Equipment Gross	1.0	1.0	0.97	0.96	0.96	-0.78	1.0	-0.91	-0.95	0.66	0.93	0.96	0.02	-0.01	1.0	0.72	1.0	0.03	1.0	0.88	1.0	0.18	0.96		1.0	1.0
Total Current Assets	1.0	0.99	0.98	0.97	0.95	-0.8	1.0	-0.93	-0.96	0.68	0.94	0.97	0.05	0.03	1.0	0.72	1.0	0.06	0.99	0.88	0.99	0.22	0.95	1.0		1.0
Capital Stock	1.0	1.0	0.96	0.95	0.97	-0.75	1.0	-0.89	-0.93	0.62	0.91	0.94	-0.04	-0.06	1.0	0.73	1.0	-0.03	1.0	0.87	1.0	0.13	0.97	1.0	1.0

Click cells to compare fundamentals

Structure Therapeutics Account Relationship Matchups

Pair Trading with Structure Therapeutics

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Structure Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Structure Therapeutics will appreciate offsetting losses from the drop in the long position's value.

Moving together with Structure Stock

0.65	A	Agilent Technologies	Pair Corr
0.72	ME	23Andme Holding	Pair Corr

Moving against Structure Stock

0.47	MDGL	Madrigal Pharmaceuticals	Pair Corr
0.45	KEP	Korea Electric Power	Pair Corr
0.38	RNXT	RenovoRx	Pair Corr

The ability to find closely correlated positions to Structure Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Structure Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Structure Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Structure Therapeutics American to buy it.

The correlation of Structure Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Structure Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Structure Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Structure Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

Additional Tools for Structure Stock Analysis

When running Structure Therapeutics' price analysis, check to measure Structure Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Structure Therapeutics is operating at the current time. Most of Structure Therapeutics' value examination focuses on studying past and present price action to predict the probability of Structure Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Structure Therapeutics' price. Additionally, you may evaluate how the addition of Structure Therapeutics to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC